Literature DB >> 2166813

The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor.

K M Klucher1, D H Spector.   

Abstract

We have examined the factors which influence the expression of a major 2.7-kilobase (kb) early transcript encoded by the long repeat of the human cytomegalovirus (HCMV) strain AD169 genome. Previously, by deletion analysis, we determined that the promoter for this early RNA consisted of multiple cis-acting elements (Klucher et al., J. Virol. 63:5334-5343, 1989). Using extracts prepared from HeLa cells as well as from infected and uninfected foreskin fibroblasts, we also obtained evidence for the interaction of a cellular factor with one of these elements. In this study, we have further defined the specificity and functional importance of this binding. On the basis of DNase I footprinting and methylation interference assays, we localized the site of interaction to a region (nucleotides -113 to -106 relative to the mRNA start site) which contains homology to the binding site for the adenovirus major late transcription factor (MLTF), also referred to as the upstream stimulatory factor (USF). The contact points of binding between the cellular factor and the guanine residues within this segment were consistent with the pattern of binding for USF/MLTF. Additionally, by using oligonucleotides containing the binding sites for USF/MLTF from the adenovirus major late promoter and the HCMV 2.7-kb RNA promoter as competitors in gel retardation assays, we were able to show that USF/MLTF bound to the two promoters with similar affinity. Correlation of the binding activity with in vivo functional importance was provided by mutagenesis and transient-expression assays. A point mutation within the HCMV USF/MLTF site lowered the affinity of binding 5- to 10-fold and decreased the inducible activity of the HCMV 2.7-kb RNA promoter by approximately 50%. Furthermore, the addition of the HCMV USF/MLTF site to a minimal 2.7-kb RNA promoter containing only the TATA sequence resulted in an increase in HCMV inducible transcriptional activity of 6- to 20-fold. However, the HCMV USF/MLTF site could not functionally substitute for the TATA sequence. These studies further support the idea that for maximal response to the HCMV infection, the 2.7-kb RNA promoter requires multiple cis-acting sequences, two of which include the binding sites for USF/MLTF and TFIID.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166813      PMCID: PMC247883          DOI: 10.1128/JVI.64.9.4189-4198.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  Diseases produced by cytomegaloviruses.

Authors:  G A Nankervis; M L Kumar
Journal:  Med Clin North Am       Date:  1978-09       Impact factor: 5.456

2.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

3.  Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection.

Authors:  M W Wathen; D R Thomsen; M F Stinski
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

4.  Human cytomegalovirus DNA: restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs.

Authors:  J M Demarchi
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

5.  Organization and expression of the immediate early genes of human cytomegalovirus.

Authors:  M F Stinski; D R Thomsen; R M Stenberg; L C Goldstein
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

6.  Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection.

Authors:  M W Wathen; M F Stinski
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

7.  Sequences upstream from the T-A-T-A box are required in vivo and in vitro for efficient transcription from the adenovirus serotype 2 major late promoter.

Authors:  R Hen; P Sassone-Corsi; J Corden; M P Gaub; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  27 in total

1.  Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression.

Authors:  Jiping Chen; Mark F Stinski
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element.

Authors:  J Chen; M F Stinski
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter.

Authors:  M C Nehls; R A Rippe; L Veloz; D A Brenner
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product.

Authors:  Y S He; L Xu; E S Huang
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  The major open reading frame of the beta2.7 transcript of human cytomegalovirus: in vitro expression of a protein posttranscriptionally regulated by the 5' region.

Authors:  G Bergamini; M Reschke; M C Battista; M C Boccuni; F Campanini; A Ripalti; M P Landini
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Authors:  J A Kerry; M A Priddy; T L Staley; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Translational regulation of the human cytomegalovirus pp28 (UL99) late gene.

Authors:  J A Kerry; M A Priddy; C P Kohler; T L Staley; D Weber; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Transcriptional regulation of the human cytomegalovirus US11 early gene.

Authors:  N H Chau; C D Vanson; J A Kerry
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome.

Authors:  C P Kohler; J A Kerry; M Carter; V P Muzithras; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Sequence, function, and regulation of the Vmw65 gene of herpes simplex virus type 2.

Authors:  R F Greaves; P O'Hare
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.